MAM
KBIO

MPM Asset Management’s KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) KBIO Stock Holding History

MPM Asset Management’s Portfolio KBIO Stock Details KBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-329,116
Closed -$11.6M – 14
2013
Q4 		$11.6M Hold
329,116
– – 3.76% 7
2013
Q3 		$11.9M Hold
329,116
– – 3.36% 8
2013
Q2 		$14.9M Buy
+329,116
New +$14.9M 6.6% 5

Other funds holding KBIO

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
WSA
Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

MPM Asset Management's KBIO Position: Q1 2014 in Review

MPM Asset Management sold out of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) in Q1 2014, closing a stake of 329,116 shares — an estimated $11.6M sold.

MPM Asset Management first reported a position in KBIO in Q2 2013 and held it in 3 quarters. The position peaked at $14.9M in Q2 2013. 48 funds tracked by Wall St. Rank hold KBIO as of Q1 2014.

  • MPM Asset Management reported no remaining KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position as of Q1 2014 after selling out during the quarter.
  • MPM Asset Management sold 329,116 KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) shares in Q1 2014, an estimated $11.6M.
  • MPM Asset Management first reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in Q2 2013 and held it in 3 quarters.
  • MPM Asset Management's KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) position peaked at $14.9M in Q2 2013.
  • 48 funds tracked by Wall St. Rank held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) as of Q1 2014.

Based on MPM Asset Management's 13F filing for Q1 2014, filed 8 May 2014.